Ireland· IE-PA-PA0678/131/001
Otrivine Extra Dual Relief 0.5mg/ml + 0.6mg/ml nasal spray, solution
A xylometazoline product containing xylometazoline hydrochloride + ipratropium bromide, registered in Ireland by Haleon Ireland Limited. The same ATC class is registered in 10 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Xylometazoline is registered in 10 of 19 countries.
Countries holding a registration under ATC R01AB06 (xylometazoline), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Xylometazoline · ATC R01AB06
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Xylometazoline hydrochloride + Ipratropium bromide
- Manufacturer
- Haleon Ireland Limited
- Country
- Ireland (IE)
- ATC code
- R01AB06
- ATC class
- Xylometazoline
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0678/131/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
63 interactions on record for xylometazoline.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Xylometazoline · interactions on record
63 records
- 6 severe
- 54 moderate
Most severe, free to view
- MethylergometrineG02AB01severe
- DihydroergotamineN02CA01severe
- ErgotamineN02CA02severe
- MethysergideN02CA04severe
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Xylometazoline in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandOtrivin ipra MAXInPharm Sp. z o.o.
- CzechiaOTRIVIN DUOHaleon Czech Republic s.r.o., Praha
- SwedenOtrivin Comp 0,5 mg/ml + 0,6 mg/ml Nässpray, lösningHaleon Denmark ApS
- FinlandOtrivin CompHaleon Denmark ApS
- NorwayOtrivin CompHaleon Denmark ApS
- NetherlandsOtrivin Duo Xylometazolinehydrochloride & Ipratropiumbromide, 0,5/0,6 mg/ml, neusspray, oplossingHaleon Netherlands B.V.
- SpainRHINOVIN DUO 0,5 mg/ml + 0.6 mg/ml SOLUCION PARA PULVERIZACION NASALHaleon Spain S.A.
- United KingdomOtrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal sprayHaleon UK Trading Ltd
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Otrivin Duo
- Belgium · Otrivine Duo
- Cyprus · Otrivin Advance
- Czechia · Otrivin Duo
- Denmark · Otrivin Comp, Zymelin Plus
- Estonia · Otrivin Total
- Spain · Rhinovin Duo
- Finland · Otrivin Comp
- United Kingdom (Northern Ireland) · Otrivine Extra Dual Relief
- Greece · Otrivin Advance
- Croatia · Ksilometazolinklorid/Ipratropijev Bromid Acino, Nasoryl
- Hungary · Otrivin Komplex
- Iceland · Otrivin Comp
- Italy · Rinazina Doppia Azione
- Lithuania · Otriduo
- Luxembourg · Otrivine Duo
- Latvia · Otrivin Total
- Malta · Otrivine Extra Dual Relief
- Netherlands · Otrivin Duo
- Norway · Otrivin Comp, Zycomb
- Poland · Otrivin Ipra Max
- Portugal · Nasitrim Duoeffect, Vibrocil Actilongduo
- Romania · Rhinxyl Plus, Vibrocil Duo
- Sweden · Otrivin Comp, Zymelin Comp
- Slovenia · Maresyl Comb, Otrivin Duo
- Slovakia · Otrivin Duo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d1792f86-c389-4217-8747-77d74230b824 GET /v1/drugs/d1792f86-c389-4217-8747-77d74230b824?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Nasal spray, solution",
"routes": [
"Nasal use"
],
"source": "hpra",
"atc_all": [
"R01AB",
"R01AB06"
],
"strength": null,
"pa_number": "PA0678/131/001",
"substances": [
"Xylometazoline hydrochloride",
"Ipratropium bromide"
],
"legal_basis": "Fixed combination application (Article 10b of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "18/12/2012",
"dispensing_status": "Product not subject to medical prescription",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about xylometazoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.